Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06905912 · ClinicalTrials.gov registry record · NA
Comparison Between Spectacles and Contact Lenses
A NA study of Photophobia, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06905912 is a NA study of Photophobia that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 200 participants, above the 59-participant average among 3 other Photophobia trials with a reported enrollment target (239% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06905912, a NA study of Photophobia, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Many people suffer from migraine headaches, some more so than others and a common trigger/complaint is light sensitivity, or photophobia1. Some will go to great lengths to avoid light: a dark room with sunglasses on and blankets over the windows, often missing work/school/social activities, etc. Several ocular conditions are accompanied by photophobia, ranging from mild to debilitating.
Conditions Studied
Interventions
- DEVICE Biomedics55 Premier contact lenses, and Altius Tinted Contact Lenses
Study Locations (1)
Oklahoma
- Dean McGee Eye Institute - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-12-10 |
| Est. Completion | 2025-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06905912
The ClinicalTrials.gov registry entry for NCT06905912 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 59-participant average among 3 other Photophobia trials with a reported enrollment target (239% higher). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Photophobia appearing as the primary indexed condition, and to 1 intervention - of which Biomedics55 Premier contact lenses, and Altius Tinted Contact Lenses is the first listed.
NCT06905912 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06905912 about?
NCT06905912 is a clinical study titled "Comparison Between Spectacles and Contact Lenses". Many people suffer from migraine headaches, some more so than others and a common trigger/complaint is light sensitivity, or photophobia1. Some will go to great lengths to avoid light: a dark room with sunglasses on and blankets over the windows, often missing work/school/social activities, etc. Sev...
What is the current status of trial NCT06905912?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-12-10. Estimated completion is 2025-09-01.
What conditions does trial NCT06905912 study?
This clinical trial studies the following conditions: Photophobia.
What interventions are being tested in trial NCT06905912?
The interventions under investigation include: Biomedics55 Premier contact lenses, and Altius Tinted Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT06905912?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06905912 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Photophobia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.